Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.560
-0.080 (-4.88%)
At close: Feb 21, 2025, 4:00 PM
1.610
+0.050 (3.21%)
After-hours: Feb 21, 2025, 6:27 PM EST
OTLK's stock price has decreased by -82.02% in the past year and price targets may not have had time to catch up.
Outlook Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$12.00
Upside
+669.23%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $3 | Strong Buy | Maintains | $30 → $3 | +92.31% | Feb 18, 2025 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 | Hold | Maintains | $3 | +92.31% | Feb 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +669.23% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,823.08% | Jan 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 2, 2024 |
| BTIG | BTIG | Strong Buy Maintains $50 → $9 | Strong Buy | Maintains | $50 → $9 | +476.92% | Nov 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,823.08% | Nov 29, 2024 |
| BTIG | BTIG | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +3,105.13% | Oct 18, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +2,015.38% | Sep 3, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $53 | Strong Buy | Maintains | $53 | +3,297.44% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,823.08% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,823.08% | May 17, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +3,105.13% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +1,823.08% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +3,746.15% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +2,464.10% | Jan 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.